文献速递免疫规划传染病防控与疫情报告

海地单价轮状病毒疫苗对轮状病毒及马样G3P[8]基因型住院的保护效果

Effectiveness of monovalent rotavirus vaccine against hospitalizations due to all rotavirus and equine-like G3P[8] genotypes in Haiti 2014-2019.
PubMed 文献 · Vaccine · 2021-06-27

海地2014年引入2剂单价轮状病毒疫苗,本研究采用病例阴性设计评估其对6-59月龄儿童急性胃肠炎住院的保护效果。共纳入129例轮状病毒阳性病例和543例阴性对照,其中60%病例为马样G3P[8]基因型。2剂疫苗对任何轮状病毒株住院的保护效果为66%(95%CI: 44,80),对马样G3P[8]基因型住院的保护效果为64%(95%CI: 33,81)。

要点

  • 2剂单价轮状病毒疫苗对任何轮状病毒株住院的保护效果为66%(95%CI: 44,80)。
  • 对马样G3P[8]基因型住院的保护效果为64%(95%CI: 33,81)。
  • 结果支持轮状病毒疫苗使用并强调全程接种的重要性。

核心结论

  • 2剂单价轮状病毒疫苗对海地儿童任何轮状病毒株及马样G3P[8]基因型住院均有中等保护效果。

研究设计与样本

  • 研究采用病例阴性设计,2014年5月至2019年9月在海地哨点监测医院招募6-59月龄急性水样腹泻住院儿童。
  • 共纳入129例(19%)轮状病毒阳性病例和543例(81%)阴性对照,仅纳入符合接种条件的儿童。

主要发现

  • 病例中77例(60%)为马样G3P[8]基因型阳性。
  • 2剂疫苗对任何轮状病毒株住院的保护效果为66%(95%CI: 44,80)。
  • 2剂疫苗对马样G3P[8]基因型住院的保护效果为64%(95%CI: 33,81)。

关键数值与推荐

  • 儿童在入组前≥14天接种疫苗即视为已接种。
  • 采用非条件logistic回归计算比值比,疫苗效果(VE)按(1-比值比)×100%计算。

临床怎么用

  • 结果支持海地继续使用单价轮状病毒疫苗并促进全程2剂接种。
  • 为加勒比地区及马样G3P[8]基因型的疫苗效果评估提供首次数据。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Rotavirus vaccines are effective in preventing severe rotavirus. Haiti introduced 2-dose monovalent (G1P[8]) rotavirus vaccine recommended for infants at 6 and 10 weeks of age in 2014. We calculated the effectiveness of rotavirus vaccine against hospitalization for acute gastroenteritis in Haiti. METHODS: We enrolled children 6-59 months old admitted May 2014-September 2019 for acute watery diarrhea at any sentinel surveillance hospital. Stool was tested for rotavirus using enzyme immunoassay (EIA) and genotyped with multiplex one-step RT-PCR assay and Sanger sequencing for stratification by genotype. We used a case-negative design where cases were children positive for rotavirus and controls were negative for rotavirus. Only children eligible for vaccination were included and a child was considered vaccinated if vaccine was given ≥ 14 days before enrollment. We used unconditional logistic regression to calculate odds ratios and calculated 2-dose and 1-dose vaccine effectiveness (VE) as (1 - odds ratio) * 100. RESULTS: We included 129 (19%) positive cases and 543 (81%) negative controls. Among cases, 77 (60%) were positive for equine-like G3P[8]. Two doses of rotavirus vaccine were 66% (95% CI: 44, 80) effective against hospitalizations due to any strain of rotavirus and 64% (95% CI: 33, 81) effective against hospitalizations due to the equine-like G3P[8] genotype. CONCLUSIONS: These findings are comparable to other countries in the Americas region. To the best of our knowledge, this is the first VE estimate both against the equine-like G3P[8] genotype and from a Caribbean country. Overall, these results support rotavirus vaccine use and demonstrate the importance of complete vaccination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Burnett E, Juin S, Esona MD, et al. Effectiveness of monovalent rotavirus vaccine against hospitalizations due to all rotavirus and equine-like G3P[8] genotypes in Haiti 2014-2019. Vaccine. 2021. PMID: 34187708. doi:10.1016/j.vaccine.2021.06.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。